Andre R. Gazdag, M.D.

Practice: OrthoBethesda

Specialty: Foot and Ankle

Office locations: Bethesda, MD

Most recent review: 3 days ago New
4.9 out of 5
961 Ratings
456 Comments

Andre R. Gazdag is a board-certified orthopedic surgeon. He is specially trained to treat all conditions of the foot and ankle including those related to rheumatoid arthritis, diabetes, and trauma.

4.9 out of 5
961 Ratings
456 Comments

Andre R. Gazdag is a board-certified orthopedic surgeon. He is specially trained to treat all conditions of the foot and ankle including those related to rheumatoid arthritis, diabetes, and trauma.

The reviews listed below were collected independently of OrthoBethesda through rater8. Each review represents an authentic and verified patient experience.

Great doctor!

Rated 5 out of 5 stars
(3 days ago) Oct-2026

Listens - explains & encourages for continued improvements without unrealistic expectations. Superior Doctor!

Rated 5 out of 5 stars
(1 week ago) Oct-2026

Very patient and considerate.

Rated 5 out of 5 stars
(1 week ago) Oct-2026

Well, he explained me in details of what’s the problem with my ankle and foot so it was much better this time but I had a long wait in the waiting room. Thanks.

Rated 5 out of 5 stars
(1 week ago) Oct-2026

Dr Gazdag is very professional and friendly! I like him! He is a good doctor!

Rated 5 out of 5 stars
(1 week ago) Oct-2026

Dr Gaza’s was very informative and provided me with immediate relief for the time being and options for healing moving forward.

Rated 5 out of 5 stars
(2 weeks ago) Oct-2026

Professional and provided a thorough diagnosis and multiple solutions to alleviate the pain.

Rated 5 out of 5 stars
(3 weeks ago) Oct-2026

Excellent physician who inspired trust to me in his medical care. Answered all my questions and made me feel more positive than I had been in awole

Rated 5 out of 5 stars
(3 weeks ago) Oct-2026

Very nice, extremely professional, & knowledgeable 😊

Rated 5 out of 5 stars
(3 weeks ago) Oct-2026

Very polite and caring doctor.

Rated 4 out of 5 stars
(3 weeks ago) Oct-2026